LOW MATERNAL SERUM LEVELS OF PREGNANCY ASSOCIATED PLASMA PROTEIN-A (PAPP-A) IN THE 1ST TRIMESTER IN ASSOCIATION WITH ABNORMAL FETAL KARYOTYPE

被引:111
作者
BRAMBATI, B [1 ]
MACINTOSH, MCM [1 ]
TEISNER, B [1 ]
MAGUINESS, S [1 ]
SHRIMANKER, K [1 ]
LANZANI, A [1 ]
BONACCHI, I [1 ]
TULUI, L [1 ]
CHARD, T [1 ]
GRUDZINSKAS, JG [1 ]
机构
[1] LONDON HOSP,ACAD UNIT OBSTET & GYNAECOL,WHITECHAPEL,LONDON E1 1BB,ENGLAND
来源
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY | 1993年 / 100卷 / 04期
关键词
D O I
10.1111/j.1471-0528.1993.tb12973.x
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective To assess the relation between maternal serum pregnancy associated plasma protein A (PAPP-A) in the first trimester and the outcome of pregnancy by karyotype. Design A retrospective study of PAPP-A levels in blood samples collected prior to chorionic villus sampling. Setting Milan, Italy. Subjects Five hundred twenty-two women, aged 20 to 47, at 7 to 11 weeks gestation, prior to undergoing chorionic villus sampling. Four hundred forty-five women had a pregnancy with a normal karyotype; in 30 pregnancies the karyotype was abnormal (including 14 cases of Down's syndrome and 7 of trisomy 18). Main outcome measures Normal or abnormal fetal karyotype. Serum PAPP-A at 6 to 11 weeks gestation measured by radioimmunoassay. Results The median value of PAPP-A in the abnormal group was 0.27 multiples of the normal median (MoM). This is significantly lower than the median value in the normal group (1.01 MoM) (95% CI for the difference 0.46-0.84 MoM; P<0.00001 Mann-Whitney test). Conclusions There is an association between low levels of PAPP-A in the first trimester with chromosome anomalies. Screening by measurement of PAPP-A might detect 60% of cases of Down's syndrome in the first trimester with a false positive rate of 5%.
引用
收藏
页码:324 / 326
页数:3
相关论文
共 20 条
  • [1] BARKAI G, 1987, LANCET, V2, P389
  • [2] BRAMBATI B, 1986, LANCET, V2, P165
  • [3] BRAMBATI B, 1991, EMBRYO NORMAL ABNORM, P181
  • [4] 1ST-TRIMESTER MATERNAL SERUM BIOCHEMICAL INDICATORS IN DOWN SYNDROME
    BROCK, DJH
    BARRON, L
    HOLLOWAY, S
    LISTON, WA
    HILLIER, SG
    SEPPALA, M
    [J]. PRENATAL DIAGNOSIS, 1990, 10 (04) : 245 - 251
  • [5] ESTIMATING A WOMANS RISK OF HAVING A PREGNANCY ASSOCIATED WITH DOWNS-SYNDROME USING HER AGE AND SERUM ALPHA-FETOPROTEIN LEVEL
    CUCKLE, HS
    WALD, NJ
    THOMPSON, SG
    [J]. BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1987, 94 (05): : 387 - 402
  • [6] CUCKLE HS, 1988, LANCET, V2, P851
  • [7] MATERNAL AGE SPECIFIC RATES FOR CHROMOSOME-ABERRATIONS AND FACTORS INFLUENCING THEM - REPORT OF A COLLABORATIVE EUROPEAN STUDY ON 52965 AMNIOCENTESES
    FERGUSONSMITH, MA
    YATES, JRW
    [J]. PRENATAL DIAGNOSIS, 1984, 4 : 5 - 44
  • [8] HOOK EB, 1988, AM J HUM GENET, V42, P797
  • [9] SCREENING FOR DOWNS-SYNDROME BASED ON INDIVIDUAL RISK
    LEWIS, M
    FAED, MJW
    HOWIE, PW
    [J]. BRITISH MEDICAL JOURNAL, 1991, 303 (6802) : 551 - 553
  • [10] LOW MATERNAL SERUM ALPHA-FETOPROTEIN AT 10 WEEKS GESTATION AND FETAL DOWNS-SYNDROME
    MANTINGH, A
    MARRINK, J
    DEWOLF, B
    BREED, ASPM
    BEEKHUIS, JR
    VISSER, GHA
    [J]. BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1989, 96 (04): : 499 - 500